Prof Martin K. Rutter MD, FRCP

Professor of Cardiometabolic Medicine and Honorary Consultant Physician

Full contact details
View graph of relations


  • Martin is Professor of Cardiometabolic Medicine at the University of Manchester and Honorary Consultant Physician at Manchester Diabetes Centre, Manchester Royal infirmary. His main research interest is the pathogenesis of cardiometabolic diseases such as heart disease, obesity and diabetes. He serves on the Advisory Board of the scientific journal Diabetologia where he has responsibility for cardiovascular manuscripts. He is clinical lead physician for the islet cell transplantation service and co-lead for the diabetes-renal service.


  • Martin received his undergraduate education at Edinburgh University Medical School. He was trained in Diabetes and Endocrinology in Newcastle-upon-Tyne, UK, where he received a Doctorate of Medicine degree for research work in the cardiovascular complications of diabetes. Between 2000 and 2002 was a Research Fellow in Cardiology and Endocrinology at the Lahey Clinic, MA, USA where he worked with the Framingham Heart Study team. He was a Consultant Physician in General Medicine, Diabetes and Endocrinology in Chester, UK, between 2002 and 2006; and then moved to Manchester Royal Infirmary from 2006 until 2009, where he was a Consultant Physician in General Medicine and Diabetes.
  • He is currently Professor of Cardiometabolic Medicine at the University of Manchester. Prior to this he held a HEFCE-funded Clinical Senior Lecturer post at the University of Manchester from 2009. His research is focussed on the pathogenesis of cardiometabolic disease and covers a range of areas including: sleep/chronotype; vascular stiffness; cardiovascular disease in diabetes; diabetes and malignancy; islet and pancreas transplantation and endocrine aspects of frailty. He has current research funding from National Institute for Health Research (NIHR), Innovate UK, MRC, Diabetes UK and NIHR Manchester Biomedical Research Centre.
  • Martin has publications in leading journals focusing on pathogenesis of cardiometabolic disease including several with the Framingham Heart Study and more recently with teams working with UK Biobank data. He leads several research collaborations with groups in the UK, Europe and the USA. He served as an Associate Editor for Diabetic Medicine between 2004 and 2010 (cardiovascular manuscripts), for Diabetologia between 2014 and Dec 2017 (cardiovascular manuscripts) and for Current Cardiovascular Risk Reports between 2012 and 2016. He currently served on the Advisory Board for Diabetologia.


  • MB ChB, 1985, Edinburgh University Medical School
  • DGM, 1991, Royal College of Physicians, Glasgow
  • MRCP (UK) 1991, Royal College of Physicians, UK
  • Dip Med Sci, 1994, University of Newcastle upon Tyne
  • MD, 2003, University of Newcastle upon Tyne
  • FRCP, 2005, Royal College of Physicians, Edinburgh
  • FHEA, 2013, The Higher Education Academy, UK

Memberships of committees and professional bodies

  • Diabetes UK: member, Professional Conference Organising Committee (2016 onwards); member, Science and Research Advisory Committee (2018 onwards); vice chair, Clinical Study Group (diabetes related complications; 2017 onwards)
  • European Association for the Study of Diabetes
  • American Heart Association
  • Advisory Committee on Clinical Excellence Awards, regional sub-committee member (2018 onwards)

Related information